Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury

被引:48
|
作者
Jacobs, BR
Brilli, RJ
Ballard, ET
Passerini, DJ
Smith, DJ
机构
[1] Childrens Hosp, Med Ctr, Dept Pathol, Cincinnati, OH 45229 USA
[2] Childrens Hosp, Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA
[3] Univ Akron, Dept Chem, Akron, OH 44325 USA
关键词
D O I
10.1164/ajrccm.158.5.9802114
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acute respiratory distress syndrome (ARDS) is a major cause of morbidity and mortality in critically ill patients. The associated ventilation/perfusion mismatch and pulmonary hypertension are amenable to treatment with inhaled nitric oxide (NO) gas. Compounds formed by reading NO with various nucleophiles (NONOates) release NO spontaneously and induce Vasodilation. Intratracheally administered NONOates result in selective reduction in pulmonary hypertension. We hypothesized that a nebulized NONOate would improve oxygenation and reduce pulmonary vascular resistance in oleic acid-induced acute lung injury and pulmonary hypertension. Pigs underwent catheterization of the pulmonary artery, left atrium, and right atrium, and a flow probe was positioned around the pulmonary artery. Acute lung injury and pulmonary hypertension were induced with intravenous oleic acid. Animals were randomly assigned to receive either nebulized saline or the NONOate 2-(dimethylamino)ethylputreanine/NO (DMAEP/NO). Hemodynamic, gas exchange, pulmonary function, methemoglobin, and nitrite/nitrate measurements were obtained for 60 min. Animals in the DMAEP/NO group had improvement in Pa-O2 as compared with control animals (from 139 +/- 19 mm Hg to 180 +/- 19 mm Hg in the DMAEP/NO group [n = 6]; and from 144 +/- 6 mm Hg to 150 +/- 9 mm Hg in the saline group [9 = 6], p < 0.05). After aerosol treatment, animals in the DMAEP/NO group had a greater reduction in pulmonary vascular resistance index (PVRI) than did control animals (from 81 +/- 17 dyne . s/cm(5)/kg to 34 +/- 8 dyne . s/cm(5)/kg; and from 104 +/- 16 dyne . s/cm(5)/kg to 64 +/- 11 dyne . sec/cm(5)/kg in the saline group at 60 min, p < 0.05). There were no differences between the groups in systemic vascular resistance index (SVRI), cardiac index (CI), methemoglobin, nitrite/nitrate, or lung pathology scores. We conclude that DMAEP/NO improves oxygenation and has selective pulmonary Vasodilating properties without causing significant systemic toxicity in this porcine model of acute lung injury.
引用
收藏
页码:1536 / 1542
页数:7
相关论文
共 50 条
  • [1] Soluble nitric oxide donor and surfactant improve oxygenation and pulmonary hypertension in porcine lung injury
    Jacobs, BR
    Smith, DJ
    Zingarelli, B
    Passerini, DJ
    Ballard, ET
    Brilli, RJ
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2000, 4 (04): : 412 - 422
  • [2] Soluble NO donor and surfactant improve oxygenation and pulmonary hypertension (PH) in porcine acute lung injury
    Jacobs, B
    Brilli, R
    Smith, D
    Passerini, D
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A39 - A39
  • [3] Two aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension
    Lam, CF
    van Heerden, PV
    Ilett, KF
    Caterina, P
    Filion, P
    CHEST, 2003, 123 (03) : 869 - 874
  • [4] Nitric oxide improves pulmonary vascular resistance but not oxygenation in ARDS, heart transplant, and pulmonary hypertension
    MC DaSilva
    JS Smith
    RN Cooney
    TL Bass
    SA Blosser
    Critical Care, 2 (Suppl 1):
  • [5] A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension
    Hurtsen, Anna Stene
    Nilsson, Ilya Zorikhin
    Dogan, Emanuel M.
    Nilsson, Kristofer F.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 635 - 644
  • [6] A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
    Hoeper, MM
    Olschewski, H
    Ghofrani, HA
    Wilkens, H
    Winkler, J
    Borst, MM
    Niedermeyer, J
    Fabel, H
    Seeger, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) : 176 - 182
  • [7] A Review of Inhaled Nitric Oxide and Aerosolized Epoprostenol in Acute Lung Injury or Acute Respiratory Distress Syndrome
    Dzierba, Amy L.
    Abel, Erik E.
    Buckley, Mitchell S.
    Lat, Ishaq
    PHARMACOTHERAPY, 2014, 34 (03): : 279 - 290
  • [8] Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin
    Barry, PW
    ANAESTHESIA AND INTENSIVE CARE, 1999, 27 (06) : 670 - 671
  • [9] Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin
    Tibballs, J
    Goh, TH
    McKenzie, I
    Hochman, M
    ANAESTHESIA AND INTENSIVE CARE, 1999, 27 (03) : 316 - 317
  • [10] INHALED NITRIC-OXIDE VARIABLY IMPROVES OXYGENATION AND PULMONARY-HYPERTENSION IN PATIENTS WITH ACUTE RESPIRATORY-DISTRESS SYNDROME
    MCINTYRE, RC
    MOORE, FA
    MOORE, EE
    PIEDALUE, F
    HAENEL, JS
    FULLERTON, DA
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1995, 39 (03): : 418 - 425